NCT00308074View on ClinicalTrials.gov

An Open-Label Trial of Aripiprazole in Autism Spectrum Disorders

PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

February 28, 2009

Conditions
AutismAsperger's DisorderPervasive Developmental Disorder
Interventions
DRUG

Aripiprazole

open-label, flexible-dosing

Trial Locations (1)

02155

Cambridge Health Alliance, Medford

Sponsors

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Cambridge Health Alliance

OTHER